A Phase 3,Prospective, Randomized, Double-masked, Placebo-controlled, Parallel Study to Evaluate the Efficacy, PK and Safety of 9% Dexamethasone Intraocular Injection for the Treatment of Inflammation Associatedwith Cataract Surgery
Latest Information Update: 28 Aug 2024
At a glance
- Drugs Dexamethasone (Primary)
- Indications Ocular inflammation
- Focus Therapeutic Use
- Sponsors Ocumension Therapeutics
Most Recent Events
- 27 May 2024 New trial record